GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » Quick Ratio

Liaoning Chengda Biotechnology Co (SHSE:688739) Quick Ratio : 20.80 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Liaoning Chengda Biotechnology Co's quick ratio for the quarter that ended in Mar. 2024 was 20.80.

Liaoning Chengda Biotechnology Co has a quick ratio of 20.80. It generally indicates good short-term financial strength.

The historical rank and industry rank for Liaoning Chengda Biotechnology Co's Quick Ratio or its related term are showing as below:

SHSE:688739' s Quick Ratio Range Over the Past 10 Years
Min: 7.94   Med: 20.18   Max: 36.43
Current: 20.8

During the past 11 years, Liaoning Chengda Biotechnology Co's highest Quick Ratio was 36.43. The lowest was 7.94. And the median was 20.18.

SHSE:688739's Quick Ratio is ranked better than
93.01% of 1545 companies
in the Biotechnology industry
Industry Median: 3.6 vs SHSE:688739: 20.80

Liaoning Chengda Biotechnology Co Quick Ratio Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co Quick Ratio Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.62 11.89 25.65 26.47 19.13

Liaoning Chengda Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.43 22.92 19.25 19.13 20.80

Competitive Comparison of Liaoning Chengda Biotechnology Co's Quick Ratio

For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liaoning Chengda Biotechnology Co's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Liaoning Chengda Biotechnology Co's Quick Ratio falls into.



Liaoning Chengda Biotechnology Co Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Liaoning Chengda Biotechnology Co's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(7248.921-422.424)/356.786
=19.13

Liaoning Chengda Biotechnology Co's Quick Ratio for the quarter that ended in Mar. 2024 is calculated as

Quick Ratio (Q: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(7237.358-455.194)/326.104
=20.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liaoning Chengda Biotechnology Co  (SHSE:688739) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Liaoning Chengda Biotechnology Co Quick Ratio Related Terms

Thank you for viewing the detailed overview of Liaoning Chengda Biotechnology Co's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Liaoning Chengda Biotechnology Co (SHSE:688739) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Executives
Li Ning Director
Cui Jian Wei senior management
Chen Xin senior management
Zhang Shu Min Director
Zhou Li Bao senior management
Yuan De Ming senior management
Gao Jun Director
Yang Xu Director

Liaoning Chengda Biotechnology Co (SHSE:688739) Headlines

No Headlines